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 
Abstract— The aim of the present study was to analyze the 
magnetoencephalogram (MEG) background activity from 
patients with Alzheimer’s disease (AD) and elderly control 
subjects. MEG recordings from 20 AD patients and 21 controls 
were analyzed by means of two spectral (median frequency and 
spectral entropy) and two non-linear parameters (approximate 
entropy and Lempel-Ziv complexity). In the AD diagnosis, the 
highest accuracy of 75.6% (80% sensitivity, 71.4% specificity) 
was obtained with the median frequency according to a linear 
discriminant analysis (LDA) with a leave-one-out cross-
validation procedure. Moreover, we wanted to assess whether 
these spectral and non-linear analyses could provide 
complementary information to improve the AD diagnosis. After 
a forward stepwise LDA with a leave-one-out cross-validation 
procedure, one spectral (median frequency) and one non-linear 
parameter (approximate entropy) were selected. In this model, 
an accuracy of 80.5% (80.0% sensitivity, 81.0% specificity) was 
achieved. We conclude that spectral and non-linear analyses 
from MEG spontaneous activity could be complementary 
methods to help in AD detection. 
 
Index Terms— Alzheimer’s Disease, approximate entropy, 
Lempel-Ziv complexity, magnetoencephalogram, median 
frequency, spectral entropy. 
I. INTRODUCTION 
LZHEIMER’S disease (AD) is a neurodegenerative 
disorder characterized by the presence of amyloid plaques 
and neurofibrillary tangles  in the brain, accompanied by the 
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loss of cortical neurons and synapses [1]. AD is the most 
common form of dementia, accounting for 50-60% of all cases. 
The prevalence of dementia is below 1% in individuals aged 
60-64 years, but it shows an almost exponential increase with 
age. In people aged 85 years or older, the prevalence is 
between 24% and 33% in the western world [2]. Usually, AD 
starts by destroying neurons in parts of the brain that are 
responsible for learning and memory. Then, it affects the brain 
areas involved in language and reasoning. Finally, individuals 
may suffer changes in personality and behavior, and even lose 
their ability to communicate and recognize friends and family 
members. Although a definite diagnosis is only possible by 
necropsy, a differential diagnosis with other types of dementia 
should be attempted. Hence, new approaches are needed to 
improve AD detection. It is particularly interesting to detect 
mild cognitive impairment (MCI). This disorder shares several 
neuropathological and functional characteristics with AD [1]. 
In this sense, the memory-predominant subtype amnestic MCI 
is usually considered as a prodromal phase of AD, which is 
supported by the high conversion rate to AD exhibited by this 
group of patients [1]. 
The utility of the electromagnetic brain activity in AD 
detection [3] has been researched in the last decades from 
electroencephalogram (EEG) and magnetoencephalogram 
(MEG) signals. EEG and MEG recordings reflect slightly 
different characteristics. EEG is sensitive to all primary currents 
whereas MEG is only affected by currents flows oriented 
parallel to the scalp [4], [5]. Other difference between EEG and 
MEG arises from the insensitivity of magnetic fields to 
inhomogeneities in the head. Electrical activity is more affected 
than magnetic oscillations by skull and extracerebral brain 
tissues. Moreover, EEG rhythms can be significantly 
influenced by some technical and methodological issues, like 
distance between electrodes, sensor placement or reference 
point. On the other hand, the magnetic fields emitted by the 
brain are extremely weak. At the present, MEG signals are 
detected using large arrays of SQUIDs (superconducting 
quantum interference devices) immersed in a cryogen, which 
should be housed in a thermally insulated container. In 
addition, the MEG instrumentation should be placed in a 
magnetically shielded room to reduce the environmental noise. 
This issue increases the cost of the system and reduces both 
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the mobility and the availability of this kind of recording [5]. In 
sum, we center our study in MEG signals because this 
recording is less distorted by head structures and provides 
reference-free recordings [5]. 
Several works have focused on a spectral analysis from 
spontaneous MEG activity in AD patients. A slowing of MEG 
rhythms in AD has been observed using both relative power 
values and several spectral indexes like mean frequency, peak 
frequency and transition frequency [6], [7]. MEG studies using 
spectral entropy also reported a decrease in irregularity of AD 
patients’ MEG activity when compared with that of healthy 
controls' [7]. Both a decrease of coherence values in the alpha 
band [8] and a general decrease of coherence in all frequency 
bands [9] have been observed in AD patients’ MEG 
recordings. 
From another point of view, non-linear methods can be 
useful to analyze electromagnetic brain signals [3], [10]. Non-
linearity in the brain is introduced even at the neuronal level 
[11]. Thus, EEG and MEG appear to be an appropriate area for 
non-linear analysis, which can complement the information 
about the brain activity provided by a spectral analysis [3], 
[10], [12]. Several studies have examined the AD patients’ 
EEG/MEG recordings with non-linear analysis methods. The 
first non-linear methods applied to electromagnetic brain 
signals were the correlation dimension (D2) and the first 
Lyapunov exponent (L1) [12], [13]. Several studies have found 
that AD may produce lower D2 and L1 values [3], [13]. 
Nevertheless, there are some major drawbacks in the 
application of both D2 and L1 to EEG or MEG. Reliable 
estimation of D2 and L1 requires a large quantity of data, 
stationary and noise free time series [14]. These assumptions 
cannot be achieved for physiological data. Thus, it becomes 
necessary to apply other non-linear analyses in order to 
properly study these recordings. For example, a suitable fractal 
dimension measure has been recently applied to classify EEG 
recordings from AD patients  [15]. Other methods like 
approximate entropy (ApEn) or sample entropy have showed a 
decreased irregularity with AD [16], [17]. In addition, Lempel-
Ziv complexity (LZC) provided lower values in AD patients’ 
MEG [18]. Moreover, AD has also been studied applying 
connectivity measures such as mutual information and 
synchronization likelihood to EEG/MEG data [19]-[21]. 
The aim of the present study was  to analyze the AD patients 
and controls’ MEG background activity by means of two 
spectral (median frequency and spectral entropy) and two non-
linear parameters (ApEn and LZC). These features were 
compared to verify which obtained the highest accuracy in the 
classification of AD patients from MEG signals. Moreover, we 
wanted to assess whether these spectral and non-linear 
parameters could provide complementary information to 
improve the AD diagnosis. 
II. SUBJECTS AND MAGNETOENCEPHALOGRAM RECORDINGS 
Twenty AD patients and 21 elderly control subjects 
participated in this study, which was approved by the local 
ethics committee. Informed consent was obtained from all 
control subjects and AD patients’ caregivers. 
The AD patients (9 men and 11 women; age = 73.10 ± 9.71 
years, mean ± standard deviation, SD) were recruited from the 
“Asociación de Familiares de Enfermos de Alzheimer” in Spain. 
They fulfilled the criteria of probable AD according to the 
guidelines provided by the National Institute of Neurological 
and Communicative Disorders and Stroke – Alzheimer’s 
Disease and Related Disorders Association (NINCDS-
ADRDA) [22]. To diagnose this  dementia, brain scans (SPECT 
and MRI) and thorough medical, physical, neurological, 
psychiatric, and neurophysiological examinations were 
performed. Mini-Mental State Examination (MMSE) and 
Functional Assessment Staging (FAST) scores in this group 
were 17.70 ± 3.89 and 4.05 ± 0.39 (mean ± SD), respectively. No 
patient was receiving medication that could affect the MEG 
activity. 
Eight men and 13 women without past or present 
neurological disorders formed the control group. Their average 
age was 70.19 ± 6.96 years (mean ± SD). The MMSE and FAST 
scores for this group were 29.05 ± 0.97 and 1.71 ± 0.46 (mean ± 
SD), respectively. The difference in age between both groups 
was not significant (p-value = 0.2752, Student’s t-test). 
MEGs were recorded using a 148-channel whole-head 
magnetometer (MAGNES 2500 WH, 4D Neuroimaging) placed 
in a magnetically shielded room at the “Centro de 
Magnetoencefalografía Dr. Pérez-Modrego”, Spain. In order to 
reduce artifactual contamination, the MEGs were recorded 
while the subjects lay comfortably on a patient bed in a relaxed 
state, awake and with eyes closed. From each subject, five 
minutes of MEG background activity were acquired at a 
sampling rate of 678.19 Hz. To reduce the data length, MEGs 
were downsampled to 169.549 Hz. Afterward, they were 
digitally filtered between 1.5 Hz and 40 Hz in order to reduce 
ocular and muscle activity. An average number of 18.44 ± 7.30 
(mean ± SD) artifact-free MEG epochs of 10 s (1695 samples) 
were selected for further analysis  at each sensor for each 
subject. It should be noticed that the selection of artifact-free 
segments was based upon visual inspection by an experienced 
physician assisted with an amplitude thresholding method, 
who was blind to the subjects’ diagnosis. 
III. METHODS 
MEG epochs were analyzed by means of two spectral 
(median frequency and spectral entropy) and two non-linear 
parameters (ApEn and LZC). 
A. Median frequency (MF) 
Mean frequency and MF have been used to measure the 
changes produced by different mental disorders in EEG or 
MEG activity [3], [7], [23], [24], since they are simple indices 
that summarize the whole spectral content of the power 
spectral density (PSD). 
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Before calculating MF, the MEG power spectra were 
estimated. First of all, the autocorrelation function of each 
MEG epoch was computed. The PSD was obtained as the 
Fourier transform of the autocorrelation vector, thus being the 
spectral resolution of this study equal to 0.05 Hz. Then, MEG 
recordings were analyzed using the MF, which is defined as 
the frequency that contains 50% of the PSD power. 
Considering the 1.5 Hz – 40 Hz frequency band used in this 
study, the MF was estimated from: 
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B. Spectral entropy (SpecEn) 
SpecEn was computed in order to quantify the flatness of 
the spectrum [25]. SpecEn characterizes the distribution of 
PSD by assessing the disorder of the spectrum. Several 
studies have already applied SpecEn to analyze of EEG/MEG 
signals [25]-[28], including AD patients’ recordings [7], [17]. 
To estimate this parameter, the PSD was normalized (PSDn) so 
that   1 fPSDn . Then, the Shannon’s entropy was 
applied to the PSDn [26]: 
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 (2) 
where M is the number of frequency bins and the division by 
log(M) normalizes the SpecEn to a scale from 0 to 1 [25]. 
SpecEn can be used as an irregularity estimator [26]. High 
SpecEn values imply a broad and flat spectrum (e.g., white 
noise), whereas a predictable signal whose frequencies are 
mainly condensed into few frequency bins (e.g., a sum of 
sinusoids) provides a low SpecEn value [25]. 
C. Approximate Entropy (ApEn) 
ApEn is a family of statistics that quantifies the signal 
regularity, notwithstanding its stochastic or deterministic 
origin [29], [30]. It assigns higher values to more random data 
[29]. ApEn can be applied to short and relatively noisy time 
series and it is insensitive to infrequent artifacts or outliers, 
even those of large magnitude [30]. Thus, this statistic has 
been widely used to extract potentially useful information from 
biomedical time series [16], [27], [28], [30], [31]. 
Although ApEn was constructed along similar lines to the 
Kolmogorov-Sinai entropy, it was developed to provide a 
model-independent, widely applicable formula that could 
distinguish relatively short, noisy signals by their regularity 
[28], [30]. Consequently, ApEn avoids the problems derived 
from the application of KS entropy to biomedical data sets [29]. 
ApEn can be interpreted as a statistic which assesses the 
average of the logarithm of a conditional probability. On the 
other hand, it is an entropic measure which estimates the rate 
of new pattern generation [31]. Recent studies have shown 
that this variable depends on both the spectra and the 
probability density function of the time series [28], and 
increases with frequency and bandwidth [31]. 
ApEn has two input parameters: a run length m and a 
tolerance window r. It measures the logarithmic probability that 
runs of patterns that are close (within r) for m contiguous 
observations remain close (within the same r) on subsequent 
incremental comparisons [29], [30]. The detailed algorithm for 
the computation of ApEn from a time series, {x(i)} = x(1), x(2), 
…,x(N), of length N is as follows [29], [31]: 
1. Form N–m+1 vectors X(1), …, X(N–m+1) defined by: X(i) = 
[x(i), …, x(i+m–1)], with 1 ≤ i ≤ N–m+1. 
2. Define the distance between X(i) and X(j), d[X(i),X(j)], as 
the maximum absolute difference between their respective 
scalar components: 
        11max,
,...,1


kjxkixjXiXd
mk
.    (3) 
3. For a given X(i), count the number of j (j = 1, …, N–m+1, j 
 i) so that d[X(i), X(j)]  r, denoted as Nm(i). Then, for 1 ≤ i 
≤ N–m+1: 
     1 mNiNiC mmr .        (4) 
4. Compute the natural logarithm of each )(iCmr , and average 
it over i, 
   



1
1
ln
1
1 mN
i
m
r
m iC
mN
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5. Increase the dimension to m+1 and repeat steps 1) to 4) to 
find  iC mr
1  and  rm 1 . 
6. ApEn is estimated as [29]: 
     rrNrmApEn mm 1,,   .       (6) 
Both m and r are critical in the performance of ApEn. 
However, there are no guidelines for optimizing their values. 
Since ApEn is nearly unaffected by noise of magnitude below r 
[30], the value of this parameter should be larger than most of 
the noise [29]. In addition, for small r values, poor conditional 
probability estimations may be obtained. On the other hand, 
the accuracy and confidence of the ApEn estimation improve 
as the number of matches of length m and m+1 increases. This 
can be achieved by choosing small m and large r. However, 
some problems may arise when the matching criterion is too 
relaxed and too large r values may provoke the loss of system 
information [29].  
In this study, ApEn was computed with the established 
parameters of m = 1 and r = 0.25 times the SD of the analyzed 
signal [29]. The parameter r was normalized to give ApEn a 
translation and scale invariance. These parameters provide 
good statistical reproducibility for sequences longer than 60 
samples, as considered herein [29], [30]. 
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D. Lempel-Ziv complexity (LZC) 
LZC is a model-independent measure which evaluates the 
complexity in the Kolmogorov’s sense, also referred as 
algorithmic complexity [18], of a time series (i.e., the complexity 
of a sequence is given by the number of bits of the shortest 
computer program which can generate it) [32]. It is related to 
the number of distinct substrings and their recurrence rate 
along the signal. LZC provides higher values to more complex 
data [32]. This metric has been applied in many different areas, 
including the analysis of biomedical signals [33]. For instance, 
it was applied to EEG and MEG signals from AD patients [18], 
[34] or to assess the depth of sedation [27], [28]. Although the 
evaluation of a complexity measure in this sense seems general 
and computer-dependent, the LZC is able to avoid these 
problems [32], [35]. The reason is that its calculation needs 
only two simple operations: sequence comparison and number 
accumulation [32]. 
LZC also contains a notion of complexity in a statistical 
sense, since it is related to the Shannon’s entropy , 
characterizing the average information quantity in a signal [35]. 
Several studies have shown that LZC mainly depends on the 
signal bandwidth, although a slight dependence on the 
sequence probability density function was also found [28], 
[33]. Additionally, LZC could be interpreted as a harmonic 
variability metric [33]. Therefore, this statistic may be closely 
related to linear properties of the data. 
Due to the fact that LZC analyzes a finite symbol sequence, 
P = s(1), , s(N), the given signal must first be coarse-grained 
[27]. In this study, a binary (zeros and ones) conversion was 
used, since previous studies found that this kind of 
conversion may keep enough signal information [27], [33]. To 
compute P, the following criterion was applied [27], [33]: 
   
 
 





d
d
Tixif
Tixif
is
1
0
          
 (7) 
where Td denotes the threshold used in the coarse-grained 
conversion. In this study, Td was fixed to the median of the 
analyzed signal, since partitioning about the median is robust 
to outliers [36]. 
The string P is scanned from left to right and a complexity 
counter c(N) is increased by one unit every time a new 
subsequence of consecutive symbols is found in the scanning 
process. An example of this procedure can be found in [27]. 
Afterward, c(N) is normalized to obtain a complexity measure 
independent of the sequence length. If the number of different 
symbols is , the upper bound of c(N) is given by [32]: 
        NNNc N  log1        (8) 
where N is a small quantity and N  0 (N  ). In general, 
N/log(N) is the upper limit of c(N): 
       NNNbNc
N
loglim 

.      (9) 
For a binary conversion  = 2, b(N) ≡ N/log2(N), and c(N) 
can be normalized via b(N): 
       NbNcNC  .         (10) 
The normalized LZC reflects the arising rate of new patterns 
along with the sequence [27]. A minimum data length must be 
considered to ensure that the LZC reveals real data features. A 
previous study carried out on a similar database showed that 
the LZC values become stable for MEG signals longer than 
1000 or 1500 samples [18]. Thus, an epoch length of 1695 data 
points (10 seconds) was used in this study. 
E. Statistical analysis 
Both the Kolmogorov–Smirnov and the Shapiro–Wilk tests 
were used to assess normality of distribution, whereas 
homocedasticity was verified with Levene’s test. After the 
exploratory analysis, variables met parametric test 
assumptions. Therefore, a one-way analysis of variance 
(ANOVA) with age as a covariate was applied to assess 
statistical significance ( = 0.01). The distribution of each 
parameter was represented using notched boxplots , and 
receiver operating characteristics (ROC) curves were used to 
visually evaluate the ability of each parameter to distinguish 
between both groups. 
A linear discriminant analysis (LDA) and a forward stepwise 
LDA with a leave-one-out cross-validation scheme were 
performed to investigate group classification. Results were 
showed in terms of sensitivity (i.e., proportion of all AD 
patients for whom there is a positive test), specificity (i.e., 
percentage of healthy subjects  properly identified) and 
accuracy (i.e., total fraction of subjects well classified). 
IV. RESULTS 
A. Evaluation of MF, SpecEn, ApEn, and LZC 
In order to perform the spectral analyses, a mean PSD per 
subject and channel was obtained from the 10 s epochs in the 
148 MEG channels. These PSD functions were characterized 
with their MF and SpecEn. ApEn and LZC were calculated for 
each MEG epoch, and the corresponding values were averaged 
for every MEG channel and subject. Therefore, we obtained a 
set of 148 values per subject and parameter. Due to the high 
spatial density of the MEG channels, the problem 
dimensionality was reduced by computing the mean of the 148 
values for each subject and parameter in order to simplify 
further analyses. Thus, the statistical analyses were performed 
using only one mean value of MF, SpecEn, ApEn, and LZC per 
subject. 
Graphical summaries of the distributions from each 
parameter are depicted in Fig. 1, which shows the 
corresponding notched boxplots. The average MF value for 
the control group was 13.06 ± 2.95 Hz (mean ± SD), whereas it 
reached 9.18 ± 2.13 Hz for the AD patients. Control subjects 
had also higher entropy values than AD patients. Average 
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TABLE I 
AUC, SENSITIVITY, SPECIFICITY, AND ACCURACY OBTAINED FOR EACH 
PARAMETER AND FOR A FORWARD STEPWISE  LDA. A LEAVE-ONE-OUT 
CROSS-VALIDATION PROCEDURE WAS USED. 
 AUC 
Sensitivit
y (%) 
Specificit
y (%) 
Accuracy 
(%) 
MF 0.8571 80.0 71.4 75.6 
SpecEn 0.7809 70.0 76.2 73.2 
ApEn 0.6143 50.0 52.4 51.2 
LZC  0.7833 65.0 76.2 70.7 
LDA: MF and 
ApEn 
0.8857 80.0 81.0 80.5 
AUC: area under the ROC curve; LDA: linear discriminat analysis; MF: 
median frequency; SpecEn: spectral entropy; ApEn: approximate 
entropy; LZC: Lempel-Ziv complexity. 
SpecEn value was 0.93 ± 0.03 for the elderly control group 
while an average SpecEn value of 0.90 ± 0.03 was obtained in 
AD patients. On the other hand, ApEn was equal to 0.97 ± 0.10 
in the control group and 0.93 ± 0.09 in the AD group. Finally, 
LZC was also higher in control subjects (0.70 ± 0.05) than in 
AD patients (0.64 ± 0.05). A one-way ANOVA test with age as 
a covariate was used to assess the differences between 
groups. The corresponding p-values are also indicated in Fig. 
1. All parameters, except for ApEn, provided statistically 
significant differences (p < 0.01). 
The corresponding ROC curves are shown in Fig. 2 to 
visually evaluate the ability of each parameter to classify 
between AD patients and controls. These plots suggest that 
MF provides a better differentiation between both groups than 
the other parameters. In addition to this visual information, the 
areas under the ROC curve (AUC) for the parameters are 
shown in Table I. The AUC can be interpreted as the 
probability that a randomly chosen AD patient has a value of 
MF, SpecEn, ApEn or LZC lower than a control subject 
selected by chance. Finally, a LDA with a leave-one-out cross-
validation procedure was used to assess the classification 
performance of each parameter. Results are also included in 
Table I. The best classification was achieved using MF with an 
accuracy of 75.6%. Additionally, the accuracies provided by 
SpecEn (73.2%) and LZC (70.7%) were close to that of MF, 
whereas ApEn offered a poor classification (51.2%).  
B. Stepwise LDA 
  
(a)  (b) 
  
(c) (d) 
Fig. 1.  Notched boxplots showing the distribution of each variable averaged across all MEG channels for both groups and the corresponding p-values 
with age as a covariate. (a) Median frequency (MF). (b) Spectral entropy (SpecEn). (c) Approximate entropy (ApEn). (d) Lempel-Ziv complexity 
(LZC) 
PAPER IDENTIFICATION NUMBER: TBME-00483-2007.R1 
 
6 
After a forward stepwise LDA with a leave-one-out cross-
validation procedure, one spectral parameter (MF) and one 
non-linear parameter (ApEn) were automatically selected. The 
first variable to enter the model was MF, since it provided the 
best classification between AD patients and control subjects. 
At the next step, ApEn was added to the model used by the 
stepwise LDA to classify the subjects. The reason was that 
ApEn provided a greater discriminatory ability than SpecEn 
and LZC when used in conjunction with MF. Finally, at the last 
step, SpecEn and LZC were left out of the analysis, since they 
were linearly related to the parameters that had already been 
included into the model and provided no additional 
information. It is noteworthy that the discriminant model based 
on MF and ApEn outperformed the standard LDA with single 
parameters. In this sense, an accuracy of 80.5% (80.0% 
sensitivity, 81.0% specificity) was achieved by applying the 
classification function to the data set. This fact implies an 
increase of 4.9% in the accuracy with respect to the result 
obtained using only MF. Furthermore, the AUC achieved by 
combining MF and ApEn was higher than those obtained for 
each single parameter.  
V. DISCUSSION AND CONCLUSIONS 
We analyzed the MEG recordings from 20 AD patients and 
21 elderly control subjects by means of two spectral (MF and 
SpecEn) and two non-linear parameters (ApEn and LZC). Our 
results showed diminished MF values with significant 
differences in AD patients’ MEG. These findings are in 
agreement with previous studies, which also confirmed the 
slowing of spontaneous MEG or EEG activity in AD patients 
[3], [6]. The MF parameter reached the highest accuracy of 
75.6% (80.0% sensitivity, 71.4% specificity) with a leave-one-
out cross-validation procedure when comparing controls and 
AD patients’ MEG. 
SpecEn and ApEn values were lower in AD patients’ MEG. 
These parameters can be used as irregularity estimators [26], 
[29]. Thus, we can state that controls’ MEG background 
activity is more irregular than that of AD patients. These 
results confirm other studies where a lower irregularity in AD 
patients’ MEG or EEG was found [7], [17]. Regarding to LZC 
values, these were lower in AD patients’ MEG, indicating an 
abnormal MEG background activity in AD patients. These 
results also confirmed other research works that applied 
complexity measures to EEG/MEG recordings of AD patients 
[3], [13], [18]. 
Spectral parameters have shown a slowing of spontaneous 
MEG activity in AD. In this sense, some authors have pointed 
out that the cholinergic system modulates the spontaneous 
cortical activity at the theta and alpha bands, along with the 
functional coupling in the theta band [37]. Given that 
cholinergic deficit involves a loss of the neurotransmitter 
aceltylcholine, this fact can be partly responsible of MEG 
slowing in AD patients. Additionally, non-linear parameter 
results suggest that MEG activity from AD patients is  
characterized by a lower degree of irregularity and complexity. 
These facts could be explained by a decrease of dynamical 
complexity in some parts of the brain. However, the 
pathophysiological implications of these alterations are not 
clear. Among others, three mechanisms can be responsible for 
it: neuronal death, a general effect of neurotransmitter 
deficiency and connectivity loss of local neural networks due 
to nerve cell death [3]. Nevertheless, ageing and age-related 
diseases often accompany a wide-ranging loss of 
physiological complexity [38]. 
To improve the AD diagnosis , we wanted to assess whether 
these spectral and non-linear analyses could provide 
complementary information. We applied a forward stepwise 
LDA with a leave-one-out cross-validation procedure, which 
automatically selected a spectral parameter (MF) and a non-
linear parameter (ApEn). On the other hand, SpecEn and LZC 
  
(a) (b) 
Fig. 2. ROC curves for each parameter and for the model obtained with a forward stepwise LDA, which included MF and ApEn. (a) Spectral 
parameters (MF and SpecEn) and the LDA model. (b) Non-linear parameters (ApEn and LZC) and the LDA model. 
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did not enter the model, since they were linearly related to the 
parameters already included into the model and they did not 
improve the subject classification based on both MF and 
ApEn. Table I shows that the highest accuracy of 80.5% was 
obtained with this procedure (80.0% sensitivity, 81.0% 
specificity). This result implies that the combination of MF and 
ApEn may provide a more reliable model to detect AD than that 
obtained using single parameters. In this sense, it is 
noteworthy that the combined metric correctly detected s ome 
subjects that were misclassified by one or more single 
parameters, which is due to the fact that spectral and non-
linear measures can yield complementary information [3], [10], 
[12], useful to characterize AD. Furthermore, this compares well 
with other studies, reported by the American Academy of 
Neurology, which provide a sensitivity of 81% and specificity 
of 70% [39]. 
Some limitations of our study merit consideration. The 
sample size was small. As a result, our findings are preliminary. 
Hence, to prove the usefulness of our proposed method with 
MF and ApEn as a diagnostic tool, this approach should be 
extended to a much larger patient population. Moreover, the 
detected decrease of irregularity and complexity in the 
electromagnetic brain activity is not specific to AD. It appears 
in several physiological and pathological states including, 
among others, anesthesia [27] or vascular dementia [13]. In a 
similar sense, both EEG and MEG slowing have also been 
reported in other neurodegenerative diseases [24] and it can be 
particularly interesting to distinguish MCI patients from 
control subjects in order to predict AD [23]. Finally, it should 
be mentioned that the results from each parameter were 
averaged to simplify the analyses. This issue involves a loss of 
spatial information, which could be partially avoided by 
computing the mean of each parameter for a number of brain 
regions. However, in that case, it should be taken into account 
that a recording channel does not necessarily measure only the 
brain rhythms under that sensor, but it can reflect activity from 
other areas. 
In summary, we conclude that spectral and non-linear 
analyses could provide complement information to improve the 
AD diagnosis from MEG background activity. We achieved an 
accuracy of 80.5% (80.0% sensitivity, 81.0% specificity) after a 
forward stepwise LDA with a leave-one-out cross-validation 
procedure. In this model, a spectral parameter (MF) and a non-
linear parameter (ApEn) were selected. However, further work 
is now required to test the potential value of our methodology 
at each brain region with a larger data set and with other types 
of dementia. 
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